ロード中...
Insulin Degrading Enzyme inhibition, a novel therapy for type 2 diabetes?
The Insulin Degrading Enzyme (IDE) has been identified as a type 2 diabetes and Alzheimer’s disease susceptibility gene though its physiological function remains unclear. Maianti et al. (2014) now propose that an IDE inhibitor may be a promising therapeutic strategy for type 2 diabetes.
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4144405/ https://ncbi.nlm.nih.gov/pubmed/25100059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2014.07.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|